Drug intelligence / Profile preview

yifei sanjie wan

Development stage
Unknown
Lead developer
Guangzhou University of Chinese Medicine
Administration
Oral
01

Overview

Yifei Sanjie Wan (YFSJ) is a Traditional Chinese Medicine (TCM) formula primarily utilized in China for the treatment of non-small cell lung cancer (NSCLC). It is frequently employed as an adjunctive therapy to enhance the efficacy of chemotherapy (such as platinum-based doublets) and targeted agents like gefitinib or anlotinib. Mechanistically, YFSJ has been shown to inhibit the epithelial-mesenchymal transition (EMT) by modulating the EGFR/p-p38 MAPK/GSK3β signaling axis, thereby reducing tumor cell migration, invasion, and drug resistance. Additionally, it is being investigated for its potential to alleviate chemotherapy-induced cancer-related fatigue in lung cancer patients.

Other names
Yifei Sanjie RecipeYifei Sanjie PillYFSJ益肺散结丸
02

Targets

EGFR (Epidermal growth factor receptor)GSK3 (Glycogen synthase kinase 3 beta)MAPK14 (p38 mitogen-activated protein kinase alpha)

Beyond the preview

Go deeper on yifei sanjie wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yifei sanjie wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call